11/21
08:49 am
gri
GRI Bio Showcases GRI-0621's Potential to Reduce Inflammation, Type 1 Cytokines and Reduce Hepatic Fibrosis in Idiopathic Pulmonary Fibrosis (IPF) [Yahoo! Finance]
Low
Report
GRI Bio Showcases GRI-0621's Potential to Reduce Inflammation, Type 1 Cytokines and Reduce Hepatic Fibrosis in Idiopathic Pulmonary Fibrosis (IPF) [Yahoo! Finance]
11/21
08:45 am
gri
GRI Bio Showcases GRI-0621’s Potential to Reduce Inflammation, Type 1 Cytokines and Reduce Hepatic Fibrosis in Idiopathic Pulmonary Fibrosis (IPF)
Low
Report
GRI Bio Showcases GRI-0621’s Potential to Reduce Inflammation, Type 1 Cytokines and Reduce Hepatic Fibrosis in Idiopathic Pulmonary Fibrosis (IPF)
11/14
04:20 pm
gri
GRI Bio Reports Third Quarter 2024 Financial Results and Outlines Progress Towards Clinical Data Readout of GRI-0621 in Ongoing Phase 2a Study for Idiopathic Pulmonary Fibrosis
High
Report
GRI Bio Reports Third Quarter 2024 Financial Results and Outlines Progress Towards Clinical Data Readout of GRI-0621 in Ongoing Phase 2a Study for Idiopathic Pulmonary Fibrosis
10/24
08:30 am
gri
GRI Bio Raises a Total of $13.9 Million in Gross Proceeds Since the Beginning of 2024
Medium
Report
GRI Bio Raises a Total of $13.9 Million in Gross Proceeds Since the Beginning of 2024
10/21
05:35 pm
gri
GRI Bio Announces Exercise of Warrants
High
Report
GRI Bio Announces Exercise of Warrants
10/16
11:52 am
gri
GRI Bio Presents Positive Preclinical Data Demonstrating GRI-0621's Ability to Inhibit Invariant Natural Killer T (iNKT) Cell Activity and Reduce Important Inflammatory and Fibrotic Drivers in Idiopathic Pulmonary Fibrosis (IPF) [Yahoo! Finance]
Medium
Report
GRI Bio Presents Positive Preclinical Data Demonstrating GRI-0621's Ability to Inhibit Invariant Natural Killer T (iNKT) Cell Activity and Reduce Important Inflammatory and Fibrotic Drivers in Idiopathic Pulmonary Fibrosis (IPF) [Yahoo! Finance]
10/16
08:45 am
gri
GRI Bio Presents Positive Preclinical Data Demonstrating GRI-0621’s Ability to Inhibit Invariant Natural Killer T (iNKT) Cell Activity and Reduce Important Inflammatory and Fibrotic Drivers in Idiopathic Pulmonary Fibrosis (IPF)
High
Report
GRI Bio Presents Positive Preclinical Data Demonstrating GRI-0621’s Ability to Inhibit Invariant Natural Killer T (iNKT) Cell Activity and Reduce Important Inflammatory and Fibrotic Drivers in Idiopathic Pulmonary Fibrosis (IPF)
10/8
08:45 am
gri
GRI Bio, Inc. (NASDAQ: GRI) is now covered by analysts at Ascendiant Capital Markets. They set a "buy" rating and a $12.00 price target on the stock.
Medium
Report
GRI Bio, Inc. (NASDAQ: GRI) is now covered by analysts at Ascendiant Capital Markets. They set a "buy" rating and a $12.00 price target on the stock.
10/7
08:30 am
gri
GRI Bio to Present at the 22nd International Colloquium on Lung and Airway Fibrosis
Low
Report
GRI Bio to Present at the 22nd International Colloquium on Lung and Airway Fibrosis
9/30
08:30 am
gri
GRI Bio Granted Japan Patent for Proprietary Natural Killer T (NKT) Cell Modulators for Prevention and Treatment of Inflammatory Conditions
High
Report
GRI Bio Granted Japan Patent for Proprietary Natural Killer T (NKT) Cell Modulators for Prevention and Treatment of Inflammatory Conditions
9/26
08:00 am
gri
GRI Bio Receives Authorization to Conduct Phase 2a Biomarker Study Evaluating GRI-0621 in Australia
Low
Report
GRI Bio Receives Authorization to Conduct Phase 2a Biomarker Study Evaluating GRI-0621 in Australia
9/25
08:45 am
gri
GRI Bio (NASDAQ: GRI) to Participate in a Virtual Investor CEO Connect Segment
Low
Report
GRI Bio (NASDAQ: GRI) to Participate in a Virtual Investor CEO Connect Segment
9/18
09:00 am
gri
GRI Bio Participates in Virtual Investor KOL Connect Segment
Medium
Report
GRI Bio Participates in Virtual Investor KOL Connect Segment
9/5
08:48 am
gri
GRI Bio to Present at the H.C. Wainwright 26th Annual Global Investment Conference [Yahoo! Finance]
Medium
Report
GRI Bio to Present at the H.C. Wainwright 26th Annual Global Investment Conference [Yahoo! Finance]
9/5
08:45 am
gri
GRI Bio to Present at the H.C. Wainwright 26th Annual Global Investment Conference
Medium
Report
GRI Bio to Present at the H.C. Wainwright 26th Annual Global Investment Conference
9/4
08:50 am
gri
GRI Bio to Present at the 2024 European Respiratory Congress [Yahoo! Finance]
Medium
Report
GRI Bio to Present at the 2024 European Respiratory Congress [Yahoo! Finance]
9/4
08:45 am
gri
GRI Bio to Present at the 2024 European Respiratory Congress
Medium
Report
GRI Bio to Present at the 2024 European Respiratory Congress